View in EDS

Coordinated immune activation following KRAS inhibition in syngeneic models reveals molecular pathways that potentiate and limit antitumor immunity.

Saved in:
Bibliographic Details
Title: Coordinated immune activation following KRAS inhibition in syngeneic models reveals molecular pathways that potentiate and limit antitumor immunity.
Authors: Lu DR; Amgen Inc. South San Francisco, CA United States., Osgood T; Amgen Inc. Thousand Oaks, CA United States., Ma S; Amgen Inc. South San Francisco, CA United States., Zhang H; Amgen Inc. South San Francisco, CA United States., Kanke M; Amgen (United States) South San Franciso United States., Tan JA; Amgen (United States) South San Francisco, CA United States., Paudel SN; Amgen Inc. Thousand Oaks, CA United States., Zhou H; Amgen (United States) South San Francisco, CA United States., Estrada J; Amgen Inc. Thousand Oaks, CA United States., Yamawaki T; Amgen Inc. South San Francisco, CA United States., Tarbell K; Amgen Inc. South San Francisco, CA United States., Rex K; Amgen Inc. Thousand Oaks, CA United States., DeVoss J; Amgen (United States) South San Francisco, CA United States., Martin S; Amgen Inc. South San Francisco, CA United States., Wang S; Amgen Inc. South San Francisco, CA United States., Canon J; Amgen Inc. Thousand Oaks, CA United States., Lipford JR; Amgen (United States) United States., Coxon A; Amgen Inc. Thousand Oaks, CA United States., Li CM; Amgen (United States) South San Francisco, CA United States.
Source: Cancer immunology research [Cancer Immunol Res] 2026 Jul 03. Date of Electronic Publication: 2026 Jul 03.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42397029
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Coordinated immune activation following KRAS inhibition in syngeneic models reveals molecular pathways that potentiate and limit antitumor immunity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lu+DR%22">Lu DR</searchLink>; Amgen Inc. South San Francisco, CA United States.<br /><searchLink fieldCode="AU" term="%22Osgood+T%22">Osgood T</searchLink>; Amgen Inc. Thousand Oaks, CA United States.<br /><searchLink fieldCode="AU" term="%22Ma+S%22">Ma S</searchLink>; Amgen Inc. South San Francisco, CA United States.<br /><searchLink fieldCode="AU" term="%22Zhang+H%22">Zhang H</searchLink>; Amgen Inc. South San Francisco, CA United States.<br /><searchLink fieldCode="AU" term="%22Kanke+M%22">Kanke M</searchLink>; Amgen (United States) South San Franciso United States.<br /><searchLink fieldCode="AU" term="%22Tan+JA%22">Tan JA</searchLink>; Amgen (United States) South San Francisco, CA United States.<br /><searchLink fieldCode="AU" term="%22Paudel+SN%22">Paudel SN</searchLink>; Amgen Inc. Thousand Oaks, CA United States.<br /><searchLink fieldCode="AU" term="%22Zhou+H%22">Zhou H</searchLink>; Amgen (United States) South San Francisco, CA United States.<br /><searchLink fieldCode="AU" term="%22Estrada+J%22">Estrada J</searchLink>; Amgen Inc. Thousand Oaks, CA United States.<br /><searchLink fieldCode="AU" term="%22Yamawaki+T%22">Yamawaki T</searchLink>; Amgen Inc. South San Francisco, CA United States.<br /><searchLink fieldCode="AU" term="%22Tarbell+K%22">Tarbell K</searchLink>; Amgen Inc. South San Francisco, CA United States.<br /><searchLink fieldCode="AU" term="%22Rex+K%22">Rex K</searchLink>; Amgen Inc. Thousand Oaks, CA United States.<br /><searchLink fieldCode="AU" term="%22DeVoss+J%22">DeVoss J</searchLink>; Amgen (United States) South San Francisco, CA United States.<br /><searchLink fieldCode="AU" term="%22Martin+S%22">Martin S</searchLink>; Amgen Inc. South San Francisco, CA United States.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; Amgen Inc. South San Francisco, CA United States.<br /><searchLink fieldCode="AU" term="%22Canon+J%22">Canon J</searchLink>; Amgen Inc. Thousand Oaks, CA United States.<br /><searchLink fieldCode="AU" term="%22Lipford+JR%22">Lipford JR</searchLink>; Amgen (United States) United States.<br /><searchLink fieldCode="AU" term="%22Coxon+A%22">Coxon A</searchLink>; Amgen Inc. Thousand Oaks, CA United States.<br /><searchLink fieldCode="AU" term="%22Li+CM%22">Li CM</searchLink>; Amgen (United States) South San Francisco, CA United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101614637%22">Cancer immunology research</searchLink> [Cancer Immunol Res] 2026 Jul 03. <i>Date of Electronic Publication: </i>2026 Jul 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101614637 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2326-6074 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223266066%22">23266066 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42397029
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2326-6066.CIR-25-0794
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Coordinated immune activation following KRAS inhibition in syngeneic models reveals molecular pathways that potentiate and limit antitumor immunity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lu DR
      – PersonEntity:
          Name:
            NameFull: Osgood T
      – PersonEntity:
          Name:
            NameFull: Ma S
      – PersonEntity:
          Name:
            NameFull: Zhang H
      – PersonEntity:
          Name:
            NameFull: Kanke M
      – PersonEntity:
          Name:
            NameFull: Tan JA
      – PersonEntity:
          Name:
            NameFull: Paudel SN
      – PersonEntity:
          Name:
            NameFull: Zhou H
      – PersonEntity:
          Name:
            NameFull: Estrada J
      – PersonEntity:
          Name:
            NameFull: Yamawaki T
      – PersonEntity:
          Name:
            NameFull: Tarbell K
      – PersonEntity:
          Name:
            NameFull: Rex K
      – PersonEntity:
          Name:
            NameFull: DeVoss J
      – PersonEntity:
          Name:
            NameFull: Martin S
      – PersonEntity:
          Name:
            NameFull: Wang S
      – PersonEntity:
          Name:
            NameFull: Canon J
      – PersonEntity:
          Name:
            NameFull: Lipford JR
      – PersonEntity:
          Name:
            NameFull: Coxon A
      – PersonEntity:
          Name:
            NameFull: Li CM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 07
              Text: 2026 Jul 03
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2326-6074
          Titles:
            – TitleFull: Cancer immunology research
              Type: main
ResultId 1